IL152378A0 - Edg8 receptor, its preparation and use - Google Patents

Edg8 receptor, its preparation and use

Info

Publication number
IL152378A0
IL152378A0 IL15237801A IL15237801A IL152378A0 IL 152378 A0 IL152378 A0 IL 152378A0 IL 15237801 A IL15237801 A IL 15237801A IL 15237801 A IL15237801 A IL 15237801A IL 152378 A0 IL152378 A0 IL 152378A0
Authority
IL
Israel
Prior art keywords
preparation
receptor
polynucleotides
edg8
edg8 receptor
Prior art date
Application number
IL15237801A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00108858A external-priority patent/EP1149907A1/de
Priority claimed from EP00116589A external-priority patent/EP1178110A1/de
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL152378A0 publication Critical patent/IL152378A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
IL15237801A 2000-04-26 2001-04-14 Edg8 receptor, its preparation and use IL152378A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00108858A EP1149907A1 (de) 2000-04-26 2000-04-26 EDG8 Rezeptor, dessen Herstellung und Verwendung
EP00116589A EP1178110A1 (de) 2000-08-01 2000-08-01 EDG8 Rezeptor für Sphingosine 1-Phosphate , dessen Herstellung und Anwendung
PCT/EP2001/004283 WO2001081573A1 (en) 2000-04-26 2001-04-14 Edg8 receptor, its preparation and use

Publications (1)

Publication Number Publication Date
IL152378A0 true IL152378A0 (en) 2003-05-29

Family

ID=26070860

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15237801A IL152378A0 (en) 2000-04-26 2001-04-14 Edg8 receptor, its preparation and use
IL152378A IL152378A (en) 2000-04-26 2002-10-20 Edg8 receptor, its preparation and use

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL152378A IL152378A (en) 2000-04-26 2002-10-20 Edg8 receptor, its preparation and use

Country Status (14)

Country Link
US (2) US20020099191A1 (de)
EP (1) EP1278850B1 (de)
JP (1) JP5139617B2 (de)
KR (1) KR100790329B1 (de)
AT (1) ATE364697T1 (de)
AU (2) AU2001270489B2 (de)
BR (1) BR0110248A (de)
CA (1) CA2406725C (de)
DE (1) DE60128906T2 (de)
IL (2) IL152378A0 (de)
MX (1) MXPA02010241A (de)
NO (1) NO331197B1 (de)
NZ (1) NZ522215A (de)
WO (1) WO2001081573A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812335B1 (en) 1999-03-23 2004-11-02 The Regents Of The University Of California Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
US20040185534A1 (en) * 2000-10-02 2004-09-23 Knudsen Ida Molgaard Industrial-scale serum-free production of recombinant proteins in mammalian cells
US20040185535A1 (en) * 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells
ES2344887T3 (es) * 2000-10-02 2010-09-09 Novo Nordisk Health Care Ag Glicoformas de factor vii.
JP2005522184A (ja) * 2001-07-20 2005-07-28 アベンティス・ファーマスーティカルズ・インコーポレイテツド 新規のｇタンパク質共役受容体ｇａｖｅ８
AU2003301991A1 (en) * 2002-11-13 2004-06-03 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5)
WO2005009469A1 (ja) * 2003-07-28 2005-02-03 Sumitomo Pharmaceuticals Co., Ltd. 新規血糖調節薬及びそのスクリーニング方法
US20090191578A1 (en) * 2004-07-27 2009-07-30 Merck & Co., Inc Canis sphingosine 1-phosphate receptor isoform 5
US8791100B2 (en) 2010-02-02 2014-07-29 Novartis Ag Aryl benzylamine compounds
US9952202B2 (en) 2013-03-14 2018-04-24 Galapagos Nv Methods of identifying compounds for the treatment of fibrosis by using S1PR5

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
WO1999019513A2 (en) * 1997-10-10 1999-04-22 Lxr Biotechnology, Inc. Methods for detecting compounds which modulate the activity of an lpa receptor
EP1105480A1 (de) * 1998-08-19 2001-06-13 Millennium Pharmaceuticals, Inc. 14274 rezeptor, ein g-protein-gekoppeltes-rezeptor, das mit dem edg rezeptor-familie verwandt ist
WO2001004139A2 (en) * 1999-07-13 2001-01-18 Smithkline Beecham Corporation Human axor29 receptor
GB9923890D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide

Also Published As

Publication number Publication date
DE60128906T2 (de) 2008-02-07
NZ522215A (en) 2004-05-28
ATE364697T1 (de) 2007-07-15
KR20020097234A (ko) 2002-12-31
JP2003530882A (ja) 2003-10-21
EP1278850B1 (de) 2007-06-13
US20020099191A1 (en) 2002-07-25
AU2001270489B2 (en) 2007-03-15
CA2406725C (en) 2013-01-15
US7141383B2 (en) 2006-11-28
BR0110248A (pt) 2003-01-07
DE60128906D1 (de) 2007-07-26
EP1278850A1 (de) 2003-01-29
IL152378A (en) 2010-12-30
CA2406725A1 (en) 2001-11-01
US20030219874A1 (en) 2003-11-27
NO20025152D0 (no) 2002-10-25
JP5139617B2 (ja) 2013-02-06
KR100790329B1 (ko) 2008-01-02
NO20025152L (no) 2002-12-13
WO2001081573A1 (en) 2001-11-01
AU7048901A (en) 2001-11-07
MXPA02010241A (es) 2004-09-06
NO331197B1 (no) 2011-10-31

Similar Documents

Publication Publication Date Title
YU19903A (sh) Novi receptor nukleinskih kiselina i polipeptida
TW200631594A (en) Toll like receptor 3 antagonists, methods and uses
BG108495A (en) 5-ht receptor ligands and uses thereof
EA200300441A1 (ru) Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения
EP1357909A4 (de) Il-8-rezeptor-antagonisten
AU7048901A (en) Edg8 receptor, its preparation and use
DE60128701D1 (en) Claudin polypeptide
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
WO2003002604A3 (en) G protein coupled receptors and dna sequences thereof
WO2003018798A3 (en) G-protein coupled receptor and dna sequences thereof
WO2002002630A3 (en) Hcn polypeptides and polynucleotides and their use in therapy
WO2001012664A3 (en) Notch receptor ligands and uses thereof
WO2005046602A3 (en) Vegf receptor antagonists
SG158098A1 (en) Toll like receptor 3 antagonists, methods and uses
WO2003018066A3 (en) A murine genomic polynucleotide sequence encoding a g-protein coupled receptor and methods of use therefor
ZA200205477B (en) 5HT3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof.
WO2002020614A3 (de) Endoglin spezifisches polypeptid, seine herstellung und verwendung
AU2003234717A8 (en) Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021
WO2002030971A3 (en) Basb205 polypeptides and polynucleotides coding therefor
GB0025170D0 (en) Novel compounds
EP1576099A3 (de) Neue, das menschliche citron-kinase-polypeptid bmsnkc 0020/0021 codierende polynukleotide
GB9918208D0 (en) Novel compounds
WO2004067093A3 (en) Nk1 receptor antagonists for the treatment of functional dyspepsia
GB0025169D0 (en) Novel compounds
AU2001249078A1 (en) 27411, a novel human pgp synthase